| 000 | 01467 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514155103.0 | ||
| 264 | 0 | _c20040316 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/00001813-200309000-00014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRabinowits, Guilherme | |
| 245 | 0 | 0 |
_aFatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cSep 2003 |
||
| 300 |
_a665-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 |
_aHemolytic-Uremic Syndrome _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xdiagnostic imaging |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aHerchenhorn, Daniel | |
| 700 | 1 | _aRabinowits, Milton | |
| 700 | 1 | _aWeatge, Daniel | |
| 700 | 1 | _aTorres, Wilhermo | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 14 _gno. 8 _gp. 665-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001813-200309000-00014 _zAvailable from publisher's website |
| 999 |
_c14262734 _d14262734 |
||